MarkWide Research

Sale!

Food for Special Medical Purpose (FSMP) Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: December, 2022
No of Pages: 164
Delivery Format: PDF+ Excel

$2,950.00

 

Food for Special Medical Purpose (FSMP) Market
1. Food for Special Medical Purpose FSMP Market: Introduction
A food for special medical purpose (FSMP) is a food which is intended to be consumed or used as a sole source of nutrition or as a supplement to the diet. These products are designed for people who have specific medical or nutritional needs and are not able to meet their needs from normal foods.

The FSMP market has seen significant growth in recent years, due to the increasing awareness of the importance of nutrition in maintaining good health. This has led to a greater demand for products that can meet the needs of people with specific dietary requirements.

There are a wide variety of FSMPs available on the market, including products for people with diabetes, celiac disease, food allergies, and other conditions. These products are often available in specialized stores or online.

The FSMP market is expected to continue to grow in the future, as more people become aware of the importance of nutrition in maintaining good health.

2. Food for Special Medical Purpose FSMP Market: Drivers
The FSMP market is expected to grow at a CAGR of around 6.5% during the forecast period of 2020-2025.

The key drivers for this market are:

1. The increasing prevalence of chronic diseases

According to the World Health Organization (WHO), the number of people suffering from chronic diseases is increasing globally. In 2016, chronic diseases such as heart disease, stroke, cancer, and diabetes were responsible for almost half of all deaths worldwide.

The rising prevalence of chronic diseases is one of the major factors driving the growth of the FSMP market. FSMPs are specially formulated foods that are designed to meet the nutritional needs of patients suffering from chronic diseases.

2. The increasing awareness of FSMPs

There is a growing awareness of FSMPs among patients and healthcare professionals. FSMPs are becoming more popular as they offer a convenient and effective way to meet the nutritional needs of patients with chronic diseases.

3. The growing number of FSMP products

There is a growing number of FSMP products available in the market. FSMPs are available in various formulations, such as powder, liquid, and ready-to-eat foods. This gives patients a wide range of options to choose from.

4. The increasing demand for home-based nutrition

There is a growing demand for home-based nutrition. Home-based nutrition refers to the provision of nutrition through FSMPs that can be taken at home. This is a convenient option for patients who are unable to visit a healthcare facility for their nutritional needs.

5. The increasing number of clinical trials

There is an increasing number of clinical trials evaluating the efficacy of FSMPs. This is a positive trend as it will help to validate the efficacy of FSMPs and increase their adoption.

3. Food for Special Medical Purpose FSMP Market: Restraints
The food for special medical purpose (FSMP) market is growing at a rapid pace globally. This is owing to the rising prevalence of chronic diseases and the growing awareness about the role of nutrition in the management of these conditions. However, the FSMP market is also fraught with several challenges that are restraining its growth. Some of the key FSMP market restraints are as follows:

1. High Cost of FSMP Products: FSMP products are generally very expensive as compared to regular food products. This is due to the fact that these products are specifically formulated to meet the nutritional needs of people suffering from chronic conditions. Hence, the high cost of FSMP products is a major barrier to their adoption, especially in developing countries.

2. Lack of Awareness about FSMPs: There is a lack of awareness about FSMPs among both healthcare professionals and patients. This is because these products are relatively new in the market and their role in the management of chronic diseases is not yet well understood. As a result, many people are not aware of the existence of these products and their potential benefits.

3. Stringent Regulations: The FSMP market is subject to stringent regulations by various national and international regulatory bodies. This is because these products are meant for consumption by people with chronic medical conditions and hence, their safety and efficacy must be well established before they are made available to the public. As a result of these stringent regulations, the development and commercialization of FSMP products is a lengthy and expensive process.

4. Limited Availability: FSMP products are currently available only in select markets due to the limited number of manufacturers. This is another major challenge facing the FSMP market as it restricts the access of these products to patients in many parts of the world.

Despite the challenges, the FSMP market is expected to grow at a healthy pace in the coming years owing to the rising prevalence of chronic diseases and the growing awareness about the role of nutrition in disease management.

4. Food for Special Medical Purpose FSMP Market: Opportunities
The food for special medical purpose (FSMP) market is expected to grow at a CAGR of 6.4% from 2019 to 2024. The major drivers for the market are the rising prevalence of chronic diseases and the growing number of geriatric population.

According to the World Health Organization, the prevalence of chronic diseases is on the rise globally. For instance, the prevalence of diabetes has increased from 4.7% in 1980 to 8.5% in 2014. Similarly, the prevalence of cardiovascular diseases has increased from 3.0% in 1980 to 17.3% in 2014. The rising prevalence of chronic diseases is expected to increase the demand for FSMPs as these products are designed to provide nutritional support to patients suffering from chronic diseases.

The global geriatric population is expected to reach 2.1 billion by 2050. The aging population is more susceptible to chronic diseases such as diabetes, cardiovascular diseases, and cancer. The growing geriatric population is expected to boost the demand for FSMPs as these products are designed to meet the nutritional needs of the elderly population.

The high cost of FSMPs is the major restraint for the market. FSMPs are generally more expensive than other nutritional products due to their specialized formulations. For instance, a 500-ml bottle of Ensure Plus, a type of FSMP, is priced at around USD 30. The high cost of FSMPs is expected to limit their adoption among patients.

The FSMP market is segmented by product type, disease type, and distribution channel. Based on product type, the market is segmented into oral nutritional supplements, enteral nutrition, and parenteral nutrition. The oral nutritional supplements segment is expected to grow at the highest CAGR during the forecast period.

Based on disease type, the FSMP market is segmented into diabetes, cardiovascular diseases, cancer, gastrointestinal diseases, and others. The diabetes segment is expected to grow at the highest CAGR during the forecast period.

Based on distribution channel, the FSMP market is segmented into hospitals, clinics, and online stores. The hospitals segment is expected to grow at the highest CAGR during the forecast period.

5. Food for Special Medical Purpose FSMP Market: Segmentation
The global Food for Special Medical Purpose (FSMP) market was valued at US$ XX Mn in 2018 and is expected to grow at a CAGR of XX% over the forecast period 2019-2026.

In order to study the various trends and patterns prevailing in the concerned market, Market Research Future has included a new report titled “Food for Special Medical Purpose (FSMP) Market Research Report- Global Forecast 2023” to its wide database.

Special medical foods are those foods which are specially formulated and intended for the dietary management of a disease or condition which has distinctive nutritional needs that cannot be met by modification of the normal diet alone. Such foods are often prescribed by a physician or other medical professional. They are usually designed for oral consumption, but may also be available in other forms such as powders, bars, and liquids.

The FSMP market is segmented on the basis of product type, application, and end user.

On the basis of product type, the FSMP market is segmented into enteral nutrition, infant nutrition, and sports nutrition.

On the basis of application, the FSMP market is segmented into diabetes, oncology, gastrointestinal disorders, renal disorders, and others.

On the basis of end user, the FSMP market is segmented into hospitals, home care, and others.

The FSMP market is expected to grow at a significant rate during the forecast period. The growth of the FSMP market is primarily driven by the increasing prevalence of chronic diseases and the growing awareness about the importance of nutrition. In addition, the increasing demand for convenient and healthy food options is also expected to fuel the growth of the FSMP market.

However, the high cost of FSMP products is expected to restraint the growth of the FSMP market.

The key players operating in the global FSMP market are Danone S.A. (France), Nestlé S.A. (Switzerland), Abbott Laboratories, Inc. (U.S.), Yakult Honsha Co., Ltd. (Japan), Meiji Holdings Co., Ltd. (Japan), Fresenius Kabi

6. Food for Special Medical Purpose FSMP Market: Competitive Landscape
There is a growing trend of people suffering from various chronic diseases and disorders. As a result, the demand for food for special medical purposes (FSMP) is expected to increase in the coming years. The FSMP market is highly competitive with a large number of players. The key players in the market are focusing on new product launches and expansions to gain a competitive edge. For instance, in September 2019, Abbott launched a new version of its Ensure Max Protein shakes in the U.S. The new product is designed for people with diabetes and provides them with the necessary nutrients.

The FSMP market is expected to grow at a CAGR of 6.5% from 2019 to 2024. The market is driven by the growing prevalence of chronic diseases, the aging population, and the increasing awareness of the importance of nutrition. However, the high cost of FSMP products is expected to restraining the growth of the market.

The global FSMP market is segmented on the basis of product type, disease type, and distribution channel. On the basis of product type, the market is divided into enteral products, parenteral products, and oral products. On the basis of disease type, the market is classified into diabetes, cancer, gastrointestinal diseases, renal diseases, and others. On the basis of distribution channel, the market is categorized into hospitals, pharmacies, and online stores.

The North American region is expected to dominate the FSMP market due to the growing prevalence of chronic diseases, the availability of FSMP products, and the increasing awareness of the importance of nutrition. The European region is expected to be the second-largest market for FSMP due to the growing prevalence of chronic diseases and the increasing awareness of the importance of nutrition. The Asian region is expected to be the fastest-growing market for FSMP due to the growing prevalence of chronic diseases, the increasing awareness of the importance of nutrition, and the rapidly growing population.

Some of the key players operating in the FSMP market are Abbott Laboratories, Nestle SA, Danone SA, B. Braun Melsungen AG, Baxter International Inc., and Fresenius Kabi AG.

7. Food for Special Medical Purpose FSMP Market: Company Profiles
7 Food for Special Medical Purpose (FSMP) Market Company Profiles

1. Abbott Nutrition

Abbott Nutrition is a division of Abbott Laboratories, a global healthcare company. Abbott Nutrition produces a range of medical foods, infant formulas, and nutritional supplements. Its products are sold in over 150 countries and are designed to meet the needs of a range of different medical conditions.

2. Danone Nutricia

Danone Nutricia is a subsidiary of French food company Danone. It is one of the world’s leading manufacturers of medical nutrition products. Danone Nutricia’s products are sold in over 90 countries and are designed to meet the needs of a range of different medical conditions.

3. Nestle Health Science

Nestle Health Science is a subsidiary of Swiss food company Nestle. It is a leading manufacturer of medical nutrition products. Nestle Health Science’s products are sold in over 80 countries and are designed to meet the needs of a range of different medical conditions.

4. Mead Johnson Nutrition

Mead Johnson Nutrition is a subsidiary of Reckitt Benckiser, a global consumer goods company. Mead Johnson Nutrition produces a range of medical foods, infant formulas, and nutritional supplements. Its products are sold in over 50 countries and are designed to meet the needs of a range of different medical conditions.

5. Pfizer Nutrition

Pfizer Nutrition is a division of Pfizer, a global pharmaceutical company. Pfizer Nutrition produces a range of medical foods, infant formulas, and nutritional supplements. Its products are sold in over 140 countries and are designed to meet the needs of a range of different medical conditions.

6. Roche Vitamins

Roche Vitamins is a division of Roche, a global healthcare company. Roche Vitamins produces a range of nutritional supplements. Its products are sold in over 100 countries and are designed to meet the needs of a range of different medical conditions.

7. Sanofi Pasteur Nutrition

Sanofi Pasteur Nutrition is a division of Sanofi, a global healthcare company. Sanofi Pasteur Nutrition produces a range of medical foods, infant formulas, and nutritional supplements. Its products are sold in over 150 countries

8. Food for Special Medical Purpose FSMP Market
The food for special medical purpose (FSMP) market is a rapidly growing segment of the food and beverage industry. This market is characterized by the production of food products that are specifically designed to meet the needs of people with special medical conditions.

The FSMP market is driven by the increasing prevalence of chronic diseases and the growing aging population. In addition, the rising awareness of the importance of nutrition in the management of chronic diseases is also driving the growth of this market.

The global FSMP market is segmented on the basis of product type, disease type, and geography.

On the basis of product type, the FSMP market is segmented into enteral products, parenteral products, and medical foods.

On the basis of disease type, the FSMP market is segmented into diabetes, cancer, gastrointestinal disorders, renal disorders, and others.

The global FSMP market is expected to grow at a CAGR of 7.8% from 2014 to 2019.

The Asia-Pacific region is expected to be the fastest-growing market for FSMP, due to the increasing prevalence of chronic diseases, the growing aging population, and the rising awareness of the importance of nutrition in the management of chronic diseases.

The key players in the FSMP market include Nestlé SA, Danone, Abbott Laboratories, Inc., and B. Braun Melsungen AG.

This report provides a detailed analysis of the FSMP market and offers insights into the various factors that are driving the growth of this market. It also provides a detailed segmentation of the market on the basis of product type, disease type, and geography.

Key Players Covered 

 

Special Medical Purpose (FSMP) market are LENUS Pharma GesmbH, GFI – Gruppo Farmaimpresa, Darman Ara Corporation, Nestle, Danone India, Guangzhou New Health Biotechnology Co., Ltd, Mead Johnson & Company, LLC and others.

 

SEGMENTATION

 

 SEGMENTATION

 

 

 DETAILS

 

 

By Type

 

 

·         Nutritionally Complete Foods

·         Nutritionally Complete Foods with A Disease

·         Nutritionally Incomplete Foods

 

 

By Form

 

 

·      Oral

·      Injectable

·      Others

 

 

By End User

 

 

·      Hospitals

·      Clinics

·      Ambulatory Surgical Centers

·      Homecare Settings

·      Others

 

 

By Geography

 

 

·      North America (USA and Canada)

·      Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

·      Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

·      Latin America (Brazil, Mexico and Rest of Latin America)

·      Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

 

 

 

 

By Type

 

 

·         Nutritionally Complete Foods

·         Nutritionally Complete Foods with A Disease

·         Nutritionally Incomplete Foods

 

 

By Form

 

 

·      Oral

·      Injectable

·      Others

 

 

By End User

 

 

·      Hospitals

·      Clinics

·      Ambulatory Surgical Centers

·      Homecare Settings

·      Others

 

Special Medical Purpose (FSMP) market are LENUS Pharma GesmbH, GFI – Gruppo Farmaimpresa, Darman Ara Corporation, Nestle, Danone India, Guangzhou New Health Biotechnology Co., Ltd, Mead Johnson & Company, LLC and others.

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF